Crucial in vivo experiments showed that ΔcpsA strains failed to establish infections in mice unless mice carried mutations in NOX2, demonstrating that CpsA protects M.tb from CASM/LAP in vivo by inactivating NADPH oxidase (77). This evidence concerns the gene FMO5 and infection.